Suppr超能文献

肛管表皮样癌的治疗

Treatment of epidermoid anal canal cancer.

作者信息

Salmon R J, Fenton J, Asselain B, Mathieu G, Girodet J, Durand J C, Decroix Y, Pilleron J P, Rousseau J

出版信息

Am J Surg. 1984 Jan;147(1):43-8. doi: 10.1016/0002-9610(84)90032-1.

Abstract

Between 1968 and 1979, 183 patients with invasive epidermoid cancer of the anal canal were treated at Institut Curie. There was 156 women, 27 men with a mean age of 67 +/- 11 years (range 40 to 85 years). The initial height of the tumor was less than 4 cm (65 patients), 4 to 6 cm (98 patients), and more than 6 cm (20 patients). All the patients received radiotherapy, either preoperatively or as curative procedure. Twenty-five patients received preoperative radiotherapy, and there was no residual tumor in 9 biopsies obtained at operation. Four local recurrences were observed. One hundred fifty-eight patients received curative radiotherapy, 115 of whom did not undergo operation. Eighty were alive with no evidence of disease and good anal function with a minimum of 3 years follow-up. We observed 15 local recurrences, 4 inguinal recurrences, and 8 visceral metastases. In addition, eight patients initially had such a big tumor that radiotherapy was only a palliative procedure. Forty-three patients required a surgical procedure after this curative radiotherapy. Colostomy (12 patients) or abdominoperineal amputation (25 patients) was required for local recurrence and colostomy was required for necrosis related to radiotherapy. Five year survival was 59 percent. The survival was related to the size of the tumor (p less than 0.0001). The likelihood of retaining normal anal function with local control of the tumor was also closely related to the initial size of the tumor.

摘要

1968年至1979年间,居里研究所对183例肛管浸润性表皮样癌患者进行了治疗。其中女性156例,男性27例,平均年龄67±11岁(范围40至85岁)。肿瘤初始高度小于4cm的患者有65例,4至6cm的患者有98例,大于6cm的患者有20例。所有患者均接受了放疗,包括术前放疗或作为根治性治疗手段。25例患者接受了术前放疗,术中获取的9份活检标本中无残留肿瘤。观察到4例局部复发。158例患者接受了根治性放疗,其中115例未接受手术。80例患者存活且无疾病证据,肛门功能良好,随访时间至少3年。我们观察到15例局部复发、4例腹股沟复发和8例远处转移。此外,8例患者最初肿瘤巨大,放疗仅为姑息性治疗。43例患者在根治性放疗后需要接受手术。局部复发患者需要行结肠造口术(12例)或腹会阴联合切除术(25例),放疗相关坏死患者需要行结肠造口术。5年生存率为59%。生存率与肿瘤大小相关(p<0.0001)。肿瘤得到局部控制且保留正常肛门功能的可能性也与肿瘤初始大小密切相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验